Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2021 Aug 4.
Published in final edited form as: Toxicol Appl Pharmacol. 2021 Mar 18;418:115496. doi: 10.1016/j.taap.2021.115496

Toxicokinetic evaluation of the common indoor air pollutant, α-pinene, and its potential reactive metabolite, α-pinene oxide, following inhalation exposure in rodents

Suramya Waidyanatha 1,*, Michael Hackett 2, Sherry R Black 3, Mathew D Stout 1, Timothy R Fennell 3, Melanie R Silinski 3, Scott L Watson 3, Joseph Licause 3, Veronica G Robinson 1, Barney Sparrow 2, Reshan A Fernando 3, Stephen Cooper 3, Cynthia V Rider 1
PMCID: PMC8336714  NIHMSID: NIHMS1696642  PMID: 33744279

Abstract

The toxicokinetic behavior of α-pinene and its potential reactive metabolite, α-pinene oxide, was investigated following whole body inhalation exposure to 50 and 100 ppm α-pinene in rats and mice for 6 h per days for 7d. In both species and sexes, the maximum blood concentration (Cmax) increased more than proportionally while the increase in area under the concentration time curve (AUC) was proportional to the exposure concentration. When normalized to the calculated dose (D), both Cmax/D (male rats, 12.2–54.5; female rats, 17.4–74.1; male mice, 7.41–14.2; female mice, 6.59–13.0 (ng/mL)/(mg/kg)) and AUC/D (male rats, 28.9–31.1; female rats, 55.8–56.8; male mice, 18.1–19.4; female mice, 19.2–22.5 (h*ng/mL)/(mg/kg)) in rats were higher than in mice and in female rats were higher than in male rats; no sex difference was observed in mice. α-Pinene was eliminated from blood with half-lives between 12.2–17.4 h in rats and 6.18–19.4 h in mice. At the low dose, the ratio of α-pinene oxide to α-pinene, based on Cmax and AUC, respectively, was 0.200–0.237 and 0.279–0.615 in rats and 0.060–0.086 and 0.036–0.011 in mice demonstrating lower formation of the oxide in mice than in rats. At the high dose, the ratio decreased considerably in both species pointing to saturation of pathways leading to the formation of α-pinene oxide. α-Pinene and the oxide were quantified in the mammary glands of rats and mice with tissue to blood ratios of ≥ 23 demonstrating retention of these analytes in mammary glands. The findings of epoxide formation and species- and sex-differences in systemic exposure may be important in providing context and relating animal findings to human exposures.

Keywords: toxicokinetics, α-pinene, α-pinene oxide, inhalation exposure

1. Introduction

α-Pinene is a naturally occurring bicyclic monoterpene found in the oil of coniferous trees and hence is ubiquitous (Mercier et al., 2009). It is the major component in turpentine (a resinous exudate or extract obtained from coniferous trees) which contains 58–65% α-pinene along with ~30% β-pinene (PubChem, 2020). α-Pinene exists as a mixture of enantiomers, (+)-α-pinene and (−)-α-pinene, the composition of which can vary depending on the plant, the plant part, and the age of the plant (Phillips et al., 1999). There is an enantiomer-specificity to the odor with (+)-α-pinene producing a slightly minty odor and (−)-α-pinene producing a pine scent (de Carvalho and da Fonseca, 2006). These aromatic properties of α-pinene have led to its widespread use as fragrance and flavor ingredient (Jin 2008). α-Pinene was found in over 4000 different essential oils and in many fruits, vegetables, and herbs including cannabis (Burdock, 2010). The annual U.S. production and import volumes of α-pinene range from 10–50 million pounds (EPA, 2020; PubChem, 2020). Due to its high vapor pressure (633 Pa) and low water solubility (2.49 mg/L), α-pinene is expected to partition almost completely to air (Kim et al., 2016). Currently, there are no exposure limits set for α-pinene in the U.S. The current permissible exposure limit and recommended airborne exposure limit for turpentine is 100 ppm with a threshold limit value of 20 ppm averaged over an 8-hour work-shift (NIOSH, 2020).

The main human exposure to α-pinene is via the lumber industry (processing and use of softwoods or their by-products (e.g., turpentine)), use of turpentine as a solvent, and its use as a fragrance ingredient in a wide variety of products including personal care products (e.g., shampoos, body lotions, drugs, and natural health products), air fresheners, and household cleaners (Nazaroff and Singer, 2004). α-Pinene is also used as a flavoring agent in foods and beverages (e.g., alcoholic and non-alcoholic beverages, baked goods, frozen dairy, condiments, candy/chewing gum, meat products) (Burdock, 2010) and is listed in the U.S. FDA Substances Added to Food inventory; the Food Chemicals Codex and the EU Food Flavourings Database also list α-pinene as a flavoring agent (WHO, 2006; FCC, 2018; FDA, 2018; EU, 2020; FEMA, 2020).

Exposure data for α-pinene in the lumber industry in some countries are available in the published literature with values varying significantly depending on the country and the type of lumber industry. Geometric mean ± geometric standard deviation exposure to α-pinene in Canadian softwood lumber mills, based on personal air monitors, was reported as 0.1 ± 3.8 mg/m3 (0.018 ± 0.68 ppm) (Demers et al., 2000). Similar exposures were reported in New Zealand plywood workers with α-pinene concentrations ranging from 0.5 to 2.4 mg/m3 (0.090 to 0.43 ppm) (Fransman et al., 2003). Higher α-pinene concentrations were reported in Finnish sawmills (57–152 mg/m3; 10–27 ppm) (Rosenberg et al., 2002). Based on personal monitoring, concentrations of α-pinene ranging from 10–214 mg/m3 (1.8–38 ppm) and 0.62–28 mg/m3 (0.11–5.0 ppm) were reported in Swedish joinery shops and wood pellet manufacturing facilities, respectively. The highest levels of terpenes reported were in the Swedish lumber industry and ranged from 100 to 500 mg/m3 (18 to 90 ppm), with an average of 254 mg/m3 (~46 ppm) (Hedenstierna et al., 1983).

α-Pinene was detected in 100% of indoor air samples from 3 cities in Michigan with overall mean, median, and maximum values of 9.04, 3.16, and 139.2 μg/m3 (0.0016, 0.00057, and 0.025 ppm), respectively (Jia et al., 2008). In a National Canadian indoor air study conducted during 2009–2011, α-pinene was detected in >99% of the samples with a geometric mean concentration of 5.63 μg/m3 (Zhu et al., 2013; HC, 2020). Concentration of α-pinene in personal air samples ranged from 0.66 to 1199.74 μg/m3. The geometric means of the personal sampling measurements taken in winter and summer were 7.37 μg/m3 and 33.09 μg/m3, respectively (Zhu et al., 2013; HC, 2020). α-Pinene was detected in 39% of 59 occupational and domestic products with a mean (standard error) concentration of 41.3 (51.5) ppm (Rastogi et al., 2001). Collectively, these data suggest potential widespread human exposure to α-pinene.

The National Toxicology Program (NTP) investigated the toxicity of α-pinene in male and female rats and mice following whole body inhalation exposure to α-pinene for 6 h/d for 5 d/week (NTP, 2016). In the 2-week studies following exposure to 100–1600 ppm α-pinene (557–8915 mg/m3), all animals in the 800 and 1600 ppm groups died before the end of the study. Clinical signs of toxicity were observed in the rats exposed to ≥ 400 ppm and mice exposed to ≥ 800 ppm, as well as increased liver weights in both species. In the 3-month studies following exposure to 25–400 ppm (139–2229 mg/m3), all animals survived to the end of the study except six out of ten 400 ppm female rats that died before the end of the study. The major target organs observed were the liver, urinary system (kidney of rats and urinary bladder in mice), and male reproductive system. α-Pinene was negative in the Ames assay and the in vivo micronucleus assay (NTP, 2016). However, a study by Catanzaro et al. showed an increase in the aneugenic (chromosomal aberration) and clastogenic effects (micronuclei) in Chinese hamster V-79 cells following treatment with α-pinene, which was accompanied by increased reactive oxygen species production and mitotic alterations (Catanzaro et al., 2012).

Limited human data are available on turpentine or terpene exposure in occupational settings and cancer outcomes. A weak association was reported between respiratory cancer and exposure to terpenes (primarily α-pinene and Δ3-carene) and other heating products of pine and spruce in a case-control study of Finnish woodworkers (odds ratio, 1.33; 95% confidence interval, 0.78–2.27) (Kauppinen et al., 1993). An association between paternal exposure to turpentine and neuroblastoma in offspring was reported in another case-control study with an odds ratio of 1.9 (De Roos et al., 2001).

The toxicokinetic (TK) behavior of α-pinene has been reported in human volunteers (N=8) following a single inhalation exposure to 10, 225, or 450 mg/m3 (1.8, 40, and 81 ppm) to (+) a-pinene (Falk et al., 1990). Exposure was in an exposure chamber while doing mild physical exercise at a workload of 50 W with a duration of 2 h. α-Pinene blood concentration at the termination of exposure increased linearly with the exposure concentration, reached a maximum, and declined. For 10 and 225 mg/m3 exposures, blood α-pinene concentrations were below the limit of detection (LOD, 10 nmol/L) after 4 h and hence TK parameters were estimated only for the 450 mg/m3 exposure group. The elimination of α-pinene from blood was triphasic with alpha, beta, and gamma half-lives of 4.8, 38, and 695 min, respectively. The long half-life associated with the elimination phase (gamma half-life) suggested a high affinity of α-pinene for poorly perfused tissue (i.e., adipose tissue). The estimated clearance at 450 mg/m3 was 1.09 L/h/kg. Authors reported no difference in the observed TK behavior following exposure to 450 mg/m3 (−) α-pinene enantiomer (Falk et al., 1990). In another investigation, following inhalation of α-pinene or as turpentine, the observed TK behavior of α-pinene in humans was demonstrated to be similar (Filipsson, 1996). Urinary metabolites identified following inhalation exposure in humans to α-pinene were cis- and trans-verbenol and myrtenol (Eriksson and Levin, 1996). A case study describing the fate of monoterpenes following an intentional ingestion of pine oil (57% α-pinene, 8% β-pinene, 26% Δ3-carene, 6% limonene, and 3% other) reported poor uptake of monoterpenes from the gastrointestinal tract (Koppel et al., 1981). The major metabolites identified, borneol and bornylacetate, also differed from those identified following inhalation. TK data in rodents were not located in the literature.

Due to lack of toxicity data and potential for human exposure, the NTP is investigating the chronic toxicity of α-pinene following whole body inhalation exposure in Hsd:Sprague Dawley® SD® rats (50–200 ppm; 279–1114 mg/m3) and B6C3F1/N mice (100–400 ppm; 557–2229 mg/m3) (NTP, 2020). Generating TK data in the same strains and following a similar exposure paradigm is important to provide context for the toxicological findings and allow for comparison of rodent systemic exposure to human levels. Hence, we have performed studies to investigate the TK behavior of α-pinene in male and female rats and mice following consecutive 7 d whole-body inhalation exposure of α-pinene to 50 (~ 279 mg/m3) and 100 ppm (~ 557 mg/m3) α-pinene using the same test material used in the chronic toxicology study. In addition, TK data for the potential reactive metabolite, α-pinene oxide, was also investigated following exposure to α-pinene. Because α-pinene is lipophilic, and considering the prevalence of adipocytes in mammary gland and the sensitivity of the mammary gland to environmental exposures (Fenton, 2009), TK data in mammary gland were also generated.

2. Materials and methods

2.1. Materials

α-Pinene (CASRN 80–56-8; lot A-9211) was obtained from John D. Walsh Co., Incorporated (Ringwood NJ). The identity of the lot was confirmed by Fourier-transform infrared and 1H nuclear magnetic resonance spectroscopy, mass spectrometry, and elemental analysis. The purity was determined by gas chromatography (GC) with flame ionization detection (FID), which indicated one major peak accounting for approximately 98% of the total integrated peak area. In addition, four minor peaks with areas ≥ 0.1% of the total peak area were identified as tricyclene (~ 0.3%), camphene (~ 0.7%), β-pinene (0.1%), and d-limonene (0.1–0.25%). GC-FID with a chiral separation confirmed an enantiomeric composition of 68% (+)-α-pinene and 32% (−)-α-pinene. (2H3)α-pinene (internal standard) was purchased from AromaLAB GmbH (Planegg Germany). α-Pinene oxide (CASRN 1686–14-2, lot MKBT1323V, 96.7% purity) and (+)-limonene oxide (203719–54-4, lot MKCB017V, 97%) to be used as the internal standard for α-pinene oxide analysis were purchased from Sigma-Aldrich (Saint Louis, MO). Male Sprague Dawley (SD) rat blood and female SD rat mammary gland to be used in matrix standard and quality control (QC) sample preparation were purchased from BioIVT (Westbury, NY). All other reagents were obtained from commercial sources. Structures of α-pinene and α-pinene oxide are shown in Figure 1.

Figure 1.

Figure 1.

Structures of A) α-pinene and B) α-pinene oxide.

2.2. Animals and maintenance

Studies were conducted at Battelle (West Jefferson, OH) and were approved by their Institutional Animal Care and Use Committee. Animals were housed in a facility that is fully accredited by the Association for Assessment and Accreditation of Laboratory Animal Care International (West Jefferson, OH). Animal procedures were conducted in accordance with the “Guide for the Care and Use of Laboratory Animals” (NRC, 2011). Studies were conducted in compliance with the Food and Drug Administration Good Laboratory Practice.

Male and female Hsd:Sprague Dawley® SD® rats (~ 8 weeks-old) were obtained from Envigo (Haslett, MI). Male and female B6C3F1/N mice (~ 7 weeks-old) were obtained from Taconic Farms (Germantown, NY). The animals were quarantined for at least one week before they were randomized into exposure groups based on body weight stratification using Provantis software (Instem, Stone, UK) and used in studies. Following group assignment, animals were transferred to chambers and acclimated to conditions simulating those used during exposure for 3 days prior to exposure. Mice and rats had ad libitum access to certified, irradiated NTP 2000 feed (Ziegler Bros, Inc., Gardners, PA) except during exposure periods. Feed was used within 180 days of milling. All animals had access to city (West Jefferson, OH) tap water. Environmental conditions included: room temperature 73 ± 3 °F; relative humidity 52 ± 2%; and a 12-h light/dark cycle. Male and female rats were approximately 10-weeks old and male and female mice were approximately 9-weeks old at the time of the study initiation. Male (286–347 g) and female (193–238 g) rats were approximately 10-weeks old and male (23.0–33.8 g) and female (18.4–24.4 g) mice were approximately 9-weeks old at the time of dosing.

2.3. Study design, exposure, and sample collection

Male and female rats (N= 39/sex/exposure concentration) and mice (N = 39/sex/concentration) were exposed to 50 and 100 ppm α-pinene via whole body inhalation for 6 h/d for consecutive 7 d. Whole body inhalation (as opposed to nose-only inhalation) was selected to mimic human exposures and ensures less stress on animals (other than that from chemical exposure) making it more suitable for repeated and longer duration exposures. The details of the vapor generation system and chamber analysis for α-pinene concentration were similar to the those described previously (NTP, 2016). Briefly, α-pinene vapor was generated in a glass vaporizer column and diluted initially with heated nitrogen followed by heated air and transported into a delivery manifold. Exposure valves diverted vapor delivery to the manifold exhaust until the generation system was stable, and exposures were ready to proceed. When the exposure started, the exposure valves actuated, directing the vapor into the chamber inlet, where it was diluted with conditioned air to achieve the desired exposure concentration. Based on the initial characterization of the exposure system, the time to reach 90% (T90) of the target concentration was 12 min, thus, the animals were exposed for this time period in addition to the 6-h target duration. α-Pinene concentrations in each exposure chamber were determined using an on-line GC-FID system at least twice per hour. Prior to use, the on-line monitor was calibrated by quantitative determination of α-pinene in exposure chamber samples collected with sorbent gas sampling tubes (ORBO-32; activated coconut charcoal; Supelco; Bellefonte, PA) and analyzing by GC-FID as reported previously (NTP, 2016). Chambers were also monitored for temperature, relative humidity, inlet flow, and vacuum during exposure.

At the end of exposures, concentrations in the chambers were allowed to decline to approximately 10 ppm (100 ppm exposure group) and 7.5 ppm (50 ppm exposure group) prior to breaching (due to health and safety reasons), as estimated from previous measurements when qualifying the exposure chambers. On the final day of exposure, the start times were staggered to facilitate removal of animals for time-dependent sample collections for the study. Animals were anesthetized by CO2:O2 (70:30) and blood samples were collected in K3EDTA tubes via retroorbital plexus in rats and cardiac puncture in mice at 0.0833, 0.166, 0.250, 0.333, 0.5, 1, 2, 4, 8, 12, 24, and 48 h after exposure ended from 3 animals per timepoint and immediately placed on wet ice. The actual times for blood collection were recorded at each time point. Immediately following blood collection, each animal was humanely terminated via exsanguination and mammary glands were collected.

For quantitation of α-pinene, immediately following collection, 0.1 mL blood samples were aliquoted using a positive displacement pipet into 2-mL crimp top vials. Following addition of 50 μL of 250 ng/mL (2H3) α-pinene in ethanol:saline (1:1), vials were immediately capped and tightly crimped and stored at ≤ −60 °C. For quantitation of α-pinene oxide, the remaining blood (approximately 0.3 mL for mice and 0.6 mL for rats) was transferred into a 2-mL clear glass, screw thread vials, tightly capped and stored at ≤ −60 °C. All blood samples were frozen within 30 min of collection. Mammary glands (4th and/or 5th) were collected and trimmed of adipose tissue. For quantitation of α-pinene, samples (~100 mg/vial) were transferred to pre-weighed vials containing 18 2.3-mm stainless steel beads and exact weights were recorded. To each vial, 100 μL of 500 ng/mL (2H3) α-pinene in ethanol:saline (1:1) was added, vials were capped, and flash frozen with liquid nitrogen and transferred to ≤ −60 °C as described above for blood. For quantitation of α-pinene oxide, the remaining mammary glands were transferred into a 2-mL clear glass, screw thread vial, tightly capped and flash frozen with liquid nitrogen and transferred to ≤ −60 °C.

2.4. Exposure concentration and dose

Chamber α-pinene exposure concentration in mg/m3 was estimated using the measured chamber exposure concentration (ppm), molecular mass of α-pinene of 136.24 g/mol and a molar volume of 24.45 L/mol using the equation:

ExposureConcentrationmgm^3=ExposureConcentrationppm*Molecularweight(g/mol)24.45(L/mol) (1)

Parameters required to calculate the inhaled dose of α-pinene in mg/kg body weight per day were not experimentally determined in the study. Hence, the dose of α-pinene received in mg/kg body weight was calculated as:

Dose(mg/kg)=ConcentrationmgL*MvLmin*Exposureduration(min)Bodyweight(kg) (2)

where concentration (mg/L) = concentration (mg/m3) /1000, exposure duration was daily target duration of 6 h (360 min), and Mv is the respiratory parameter, minute volume, and was estimated as:

LnMv=b0+b1Ln(Body weight) (3)

where b0 and b1 are 0.326 and 1.050 for mice and −0.578 and 0.821 for rats (EPA, 1988; EPA, 1994). α-Pinene concentrations and calculated doses are given in Table 1. Please note that the mg/kg doses reported herein are the estimated theoretical inhaled doses and not the doses absorbed from the respiratory tract.

Table 1.

α-Pinene exposure concentrations and calculated doses in rats and mice

Nominal exposure concentration (ppm) Exposure concentration (ppm)a Exposure concentration (mg/m3)b Inhaled dose (mg/kg)c
Male rats 50 50.0 279 71
100 99.4 554 142
Female rats 50 50.0 279 77
100 99.4 554 152
Male mice 50 50.6 282 117
100 100.6 561 233
Female mice 50 50.6 282 116
100 100.6 561 231
a

Average exposure concentration determined based on the final day of exposure.

b

Calculated from ppm concentration, molecular weight of α-pinene, and molar volume as given in Equation 1.

C

Calculated from concentration in mg/m3, minute volume, and exposure duration as given in Equation 2. Dose was calculated for individual animals and the average dose for the group is shown. Body weights used were using pre-study body weights. Please note that the mg/kg dose reported herein are the estimated theoretical inhaled doses and not the doses absorbed from the respiratory tract.

2.5. Quantitation of α-pinene in blood and mammary glands

Concentrations of α-pinene in blood and mammary glands were determined using validated analytical methods employing head space (HS)-GC-mass spectrometry (MS) as described previously (Silinski et al., 2020). The methods were validated in rat blood and mammary and was demonstrated to be suitable for quantitation in mouse blood and mammary glands, respectively. Briefly, two stock solutions of α-pinene were prepared at 0.2 and 0.5 mg/mL in ethanol. A stock solution of (2H3)α-pinene to be used as the internal standard was prepared in 1:1 ethanol:saline at 250 ng/mL or 500 ng/mL. Spiking solutions (10–1000 ng/mL for blood and 100–5000 ng/mL for mammary) for calibration standards were prepared using alternate intermediate stocks by diluting with (2H3)α-pinene internal standard solution. All standard solutions were stored sealed in amber glass bottles at ambient temperature when not in use. Blood calibration standards (10, 20, 50, 100, 200, 500, and 1000 ng/mL blood) and QC (20 and 500 ng/mL blood) samples were prepared as follows. To a 100 μL aliquot of rat blood in a 2-mL crimp top vial, 50 μL of appropriate α-pinene spiking solution containing internal standard was added and samples were capped immediately with a metal crimp-top cap. To prepare method blanks, 50 μL of the internal standard solution was added to 100 μL blood. Mammary gland calibration standards (100, 250, 600, 1250, 2500, and 5000 ng/g mammary) and QC (250 and 2500 ng/g mammary) samples were prepared as follows. To 100 mg mammary gland sample in a 2-mL vial containing 18 2.3-mm stainless steel beads (BioSpec Products, Bartlesville OK), 50 μL of appropriate α-pinene spiking solution containing internal standard was added and vials were capped immediately with a metal crimp-top cap. Samples were homogenized for 2 cycles of 30 sec each using a Geno/Grinder 2010 (SPEX SamplePrep, Metuchen NJ).

Matrix calibration standards, QC samples, method blanks, and study samples (as prepared during sample collection described above) were analyzed by HS-GC-MS. Study mammary gland samples were homogenized for 2 cycles of 30 sec each, using a Geno/Grinder 2010 (SPEX SamplePrep, Metuchen NJ) prior to analysis. The analytical system consisted of a Hewlett Packard 6890 plus gas chromatograph (Agilent Technologies, Santa Clara, CA) with CTC Analytics CombiPal (Lake Elmo, MN) autosampler and a 5973 mass-selective detector (Agilent Technologies, Santa Clara, CA). An Agilent DB-5MS column (30 m × 0.25 mm, 0.25-μm film thickness) was used with helium as the carrier gas at a flow rate of 1.2 mL/min. Samples were placed in the autosampler and equilibrated for 10 min at 60 °C prior to injecting a 500-μL (blood) or 200-μL (mammary) volume of headspace in splitless mode. The GC oven was held at 40 °C for 5 min, ramped to 75 °C at 5 °C /min and then to 150 °C at 37.5 °C /min and held for 1 min. The GC injector temperature was 270 °C. The ion source was operated in electron ionization mode at 70 eV. The mass spectrometer transfer-line, ion source, and quadrupole temperatures were 300, 150, and 150 °C, respectively. The ions monitored for α-pinene and (2H3)α-pinene, respectively, were m/z 136 and 139 for quantitation along with m/z 121 and 124 as qualifier ions. The retention times for α-pinene and (2H3)α-pinene were ~ 11 min. The total run time was 15 min.

Study samples that exceeded the matrix calibration range were run by lowering the headspace volume sampled. A linear regression with 1/X2 weighting was used to relate analyte to internal standard peak area response ratio and concentration of α-pinene. The concentration of α-pinene was calculated using response ratio, the regression equation, and dilution (head space volume injected) when applicable. Each study sample set was bracketed by method blanks, matrix calibration standards, and QC samples. Data from study samples were considered valid if: the matrix calibration curve was linear (r ≥0.99); at least 75% of matrix standards were within 15% of nominal values (except at the limit of quantitation (LOQ) where it was 20%); at least 67% of the QC samples were within 15% of nominal values. All QCs were within 15% of nominal value. The LOQ for blood and mammary glands were set at 5.00 ng/mL and 100 ng/g. The LODs estimated as the standard error (SE) of the LOQ were 0.499 ng/mL and 17.7 ng/g for blood and mammary glands, respectively. Study sample blood concentrations were reported as ng/mL and mammary gland concentrations as both ng/g mammary and ng/g lipid using lipid concentration determined in the same sample. All concentrations above LOD were reported.

2.6. Quantitation of α-pinene oxide in blood and mammary glands

Concentration of α-pinene oxide was determined using a validated analytical method with GC-MS as described previously (Fernando et al., 2020). The method was validated in rat blood and was demonstrated to be suitable for quantitation in mouse blood and rat and mouse mammary glands. Briefly, two stock solutions of α-pinene oxide were prepared at 0.2 and 0.5 mg/mL in ethyl acetate. α-Pinene oxide spiking solutions (50–5000 ng/mL) to prepare calibration standards were made in the same solvent using alternating intermediate stocks. A solution of limonene oxide to be used as the internal standard was prepared in ethyl acetate at 66.7 ng/mL. All standard solutions were stored sealed in amber glass bottles at ambient temperature when not in use. Blood calibration standards (5, 10, 25, 50, 100, and 250 ng/mL blood) and QC (10, 50, and 200 ng/mL blood) samples were prepared as follows. To a 100 μL aliquot of rat blood in a 1.5 mL microcentrifuge tube, 5 μL of appropriate α-pinene oxide spiking solution was added (for method blanks 5 μL ethyl acetate was added) followed by 300 μL of internal standard solution. Samples were vortexed and centrifuged (~ 16,000 x g) and the supernatant was collected for analysis. To prepare mammary gland homogenates, to ~ 50 mg mammary gland sample in a 2 mL vial with seven 2.8-mm stainless steel beads (BioSpec Products, Bartlesville OK) 950 mL of deionized water was added and samples were homogenized for 60 sec each for 5 cycles using a Geno/Grinder 2010 (SPEX SamplePrep, Metuchen NJ). A 100-uL aliquot was extracted as described for blood.

Matrix calibration standards, QC samples, method blanks, and study samples (prepared as described above, without the addition of α-pinene oxide spiking solution) were analyzed by GC-MS. The system consisted of a Hewlett Packard 7890A gas chromatograph coupled to a 5975A mass-selective detector (Agilent Technologies, Santa Clara, CA). An Agilent DB-5MS column (30 m × 0.25 mm, 0.25-μm film thickness) was used with helium as the carrier gas at a flow rate of 1.2 mL/min. The GC oven was held at 40 °C for 5 min, ramped to 140 °C at 5 °C /min and then to 300°C at 20 °C /min and held for 5 min. The injector temperature was 200 °C. The ion source was operated in electron ionization mode at 70 eV. The mass spectrometer transfer-line, ion source, and quadrupole temperatures were 280, 230, and 150 °C, respectively. The quantitation was achieved by monitoring ions m/z 109 and 94 for α-pinene oxide and limonene oxide (internal standard), respectively. The retention times for α-pinene oxide and limonene were ~ 16.5 and 17.7 min, respectively. The total run time was 38 min.

Study samples that exceeded the matrix calibration range were diluted into the validated calibration range (5–250 ng/mL blood). A linear regression with 1/X weighing was used to relate analyte to internal standard peak area response ratio and concentration of α-pinene oxide. The concentration of α-pinene oxide was calculated using response ratio, the regression equation, homogenate volume (mammary glands only), and dilution, when applicable. Each study sample set was bracketed by method blanks, matrix calibration standards, and QC samples. QC data were assessed similarly to that described above for α-pinene and met the criteria. The LOQ and LOD, respectively were, for blood 5.00 ng/mL and 1.06 ng/mL and mammary gland 500 ng/g and 21.2 ng/g. Study blood sample concentrations were reported as ng/mL and mammary gland concentrations as both ng/g mammary and ng/g lipid using lipid concentration determined in the same sample. All concentrations above LOD were reported.

2.7. Quantitation of lipid

Lipid concentrations in mammary glands were determined using a colorimetric method (Johnson et al., 1977)(Supplemental Method 2). Because of the potential sample-to-sample variability in lipid content in mammary glands due to nature of the tissue, the same mammary gland samples used to quantitate α-pinene concentrations were used to determine the lipid content after completion of the α-pinene analysis. Similarly, an aliquot of the same homogenate used for α-pinene oxide analysis was used to quantitate lipid levels. The lipid concentration in samples were expressed as mg lipid/g mammary. Blood lipid concentrations were not determined in study samples as sample-to-sample variability in blood lipid was found to be minimal (data not shown).

2.8. Toxicokinetic analysis

Chamber concentrations (ppm) measured during animal exposures were within 10% of target concentrations (Table 1). For TK analysis, the calculated average inhaled mg/kg dose calculated was used (Table 1). Since α-pinene oxide is a metabolite of α-pinene, exposure and dose parameters of α-pinene were used for α-pinene oxide. In order to allow for the exposure chamber to decay to ~10% of target exposure concentration prior to opening the chambers for safety reasons (as described above under Section 2.3), all sample collection times were ~ 10 min higher than the nominal timepoints. Because a preliminary TK analysis showed that TK parameters did not change significantly whether adjusted or unadjusted timepoints were used, nominal collection timepoints were used for TK analysis.

The TK analysis was conducted using Phoenix WinNonlin (Version 6.4, Certara, Princeton, NJ). A variety of compartmental models were tested for blood α-pinene concentration versus time data sets. Mean concentration values for each time point were generated using the descriptive statistics module. For each compartmental model, data sets were analyzed without and with weighting factors (1Y, 1/Y2, 1/Y∧, and/or 1/Y∧2). The model and the weighting factor that resulted in the best goodness of fit (evaluated using the Akaike Information Criterion and Schwarz Bayesian Criterion) was selected as the final model. Based on this, a two-compartment model (Equation 4) with 1/y weighting was used to analyze blood α-pinene data. After the appropriate model and weighting was selected, it was used to analyze individual animal concentration data at each time point. Similar results were obtained whether individual animal concentration data or mean blood concentrations were used in the analysis. We selected to use mean data as it was more appropriate for the serial sacrifice design used in the studies.

Although mean rat blood α-pinene oxide data fitted with a two-compartment model, mean mouse blood α-pinene oxide data did not. Therefore, to allow for direct comparison, rat and mouse blood data were evaluated using noncompartmental analysis (NCA) in Phoenix WinNonlin (plasma model 200–202, with IV bolus dose route) with uniform weighting. Rat and mouse mammary α-pinene and α-pinene oxide concentration versus time data were also evaluated using NCA with uniform weighting. Mammary gland concentrations of α-pinene and α-pinene oxide unadjusted (ng analyte/g mammary) and adjusted to lipid levels (ng analyte/ng lipid) were used for TK analysis. A glossary of TK parameters estimated are given in Supplemental Table 1. Because α-pinene oxide is a metabolite of α-pinene, parameters calculated from exposure (i.e., clearance, volume, Cmax/D, AUC/D) were not reported.

C(t)=Ae−αt+Be−βt (4)

where C(t) is the concentration at time t; A and B are the intercepts of the distribution and elimination phases; α and β are the first order hybrid rate constants for distribution and terminal elimination phases.

3. Results

Study data are available in the Chemical Effects in Biological Systems (CEBS) database at: https://manticore.niehs.nih.gov/cebssearch/paper/15073/private/OPNTG33XYZ

Inhaled doses in mg/kg body weight per day were calculated for male and female rats and mice as described under Section 2.4 (Table 1 and CEBS Body Weights and Calculated Dose.xlsx). Dose was calculated for individual animals, using pre-study body weight and the average dose for an exposure group is reported (Table 1). The doses given are the estimated exposed dose and not the inhaled/absorbed dose. Since clearance and volume of distribution values generated using chamber exposure concentrations don’t provide meaningful values, the calculated mg/kg doses were used to generate such values. A second reason to use the dose was to improve comparison of the systemic exposure data between species after normalizing to the dose. Due to sample-to-sample variability in lipid levels in mammary gland samples, α-pinene and α-pinene oxide concentrations normalized to lipid levels were used to interpret the data; however, both lipid-normalized and unnormalized data are given in CEBS database. Lipid content in blood was not measured in study samples since lipid content in blood as well as sample-to sample variability was minimal based on data from a previous analysis. Mean ± standard error (SE) blood lipid concentration was 0.0045 ± 0.00011 g lipid/mL blood (unpublished data).

3.2. Blood toxicokinetics of α-pinene and α-pinene oxide in male and female rats

In male and female rats, blood α-pinene concentrations were above the LOD of the analytical method at all timepoints. Mean blood concentration versus time data were analyzed using a two-compartment model. The plots showing the data and model fits are presented in Figure 2A for female rats and Supplemental Figure 1A for males. TK parameters are given in Table 2.

Figure 2.

Figure 2.

Blood concentration versus time profiles of A) α-pinene and B) α-pinene oxide in female rats following whole body inhalation exposure to α-pinene for 7 d. Mean data for α-pinene and α-pinene oxide were analyzed using two-compartment models and non-compartmental analysis, respectively.

Table 2.

Blood toxicokinetic parameters of α-pinene and α-pinene oxide in male and female rats following inhalation exposure to α-pinene for 7 d.

Exposure concentration, ppm (Dose (D), mg/kg)a
Male Female
50 (71) 100 (142) 50 (77) 100 (152)
α-Pineneb
Cmax (ng/mL) 863 ± 92.1 7740 ± 2230 1340 ± 184 10800 ± 940
Cmax/D (ng/mL)/(mg/kg)c 12.2 54.5 17.4 71.1
Alpha half-life (h) 0.656 ± 0.185 0.151 ± 0.0446 0.702 ± 0.253 0.266 ± 0.0634
Beta half-life (h) 12.2 ± 9.15 12.8 ± 22.9 17.4 ± 16.5 17.1 ± 30.9
CL1 (mL/h/kg) 34600 ± 9990 32100 ± 27100 17900 ± 7980 17600 ± 12300
CL2 (mL/h/kg) 45300 ± 17300 50300 ± 30000 34000 ± 14800 18400 ± 13000
V1 (mL/kg) 82300 ± 8790 18300 ± 5290 57700 ± 7950 14000 ± 2510
V2 (mL/kg) 318000 ± 225000 356000± 557000 269000 ± 222000 218000± 387000
AUC (h*ng/mL) 2050 ± 592 4420 ± 3730 4300 ± 1910 8640 ± 6010
AUC/D (h*ng/mL)/(mg/kg)c 28.9 31.1 55.8 56.8
α-Pinene oxided
Cmax (ng/mL) 173 220 317 498
Lambda half-life (h) 14.2 19.2 12.6 11.6
AUC (h*ng/mL) 1260 1820 1200 1680
a

Dose (D) estimates in mg/kg are given in parenthesis.

b

Based on two compartment model with bolus input, first-order output and 1/y weighting. Values given are mean ± standard error for 3 animals.

c

Dose-normalized values were estimated by dividing by the corresponding dose.

d

Based on non-compartmental analysis. Mean values for 3 animals were used in the analysis.

Acronyms used: Cmax, maximum concentration; AUC, area under the plasma concentration versus time curve; CL, clearance; V, volume of distribution.

In male and female rats, the maximum concentration (Cmax) of α-pinene in blood increased with the exposure concentration or the dose. The increase in Cmax was more than dose-proportional as evident by dose-normalized values and females had higher exposure than males; (Cmax/D) were 12.2 and 54.5 (ng/mL)/(mg/kg) for males and 17.4 and 71.1 (ng/mL)/(mg/kg) for females (Table 2). Dose-normalized-area under the concentration curve (AUC) (AUC/D) values in males were 28.9 and 31.1 (h*ng/mL)/(mg/kg) and for females were 55.8 and 56.8 (h*ng/mL)/(mg/kg) demonstrating a dose-proportional increase with females having a 2-fold higher systemic exposure than males (Table 2). Consistent with the increase in AUC and decrease in clearance in females compared to males, the blood elimination half-lives (beta half-lives) in females (17.1–17.4 h) were slightly longer than in males (12.2–12.8 h) with no dose-related effect in either sex (Table 2).

Following exposure of male and female rats to α-pinene, a potential reactive metabolite, α-pinene oxide, was quantifiable in blood. α-Pinene oxide concentrations were above the LOD at all timepoints. Mean blood concentration of α-pinene oxide versus time data were evaluated using NCA. The plots showing the data and fits are shown in Figure 2B for female and Supplemental Figure 1B for male rats. Toxicokinetic parameters are given in Table 2. In male and female rats, Cmax and AUC of α-pinene oxide increased with the dose of α-pinene although the increase was approximately 1.3- to 1.6-fold, with a 2-fold increase in dose. Elimination half-life (lambda half-lives) of α-pinene oxide in blood was long (11.6–19.2 h) with no apparent dose- or sex-related effects (Table 2).

3.3. Mammary gland toxicokinetics of α-pinene and α-pinene oxide in male and female rats

In male and female rats, mammary gland α-pinene concentrations were above the LOD of the analytical method at all timepoints. α-Pinene in mammary gland was reported as both ng/g mammary gland and ng/g lipid. For TK analysis, mean concentration versus time data were evaluated using NCA. The plots showing the data for both ng/g mammary gland and ng/g lipid and model fits are shown for females in Figure 3A and males in Supplemental Figure 2A for males. For the purpose of the current manuscript, only the TK parameters estimated using the lipid-normalized values (ng α-pinene/g lipid) are given in Table 3.

Figure 3.

Figure 3.

Mammary gland concentration versus time profiles of A) α-pinene and B) α-pinene oxide in female rats following whole body inhalation exposure to α-pinene for 7 days. Mean data were analyzed using non-compartmental analysis. Open and closed symbols represent ng/g mammary and ng/g lipid, respectively.

Table 3.

Mammary gland toxicokinetic parameters of α-pinene and α-pinene oxide in male and female rats following inhalation exposure to α-pinene for 7 d.

Exposure concentration, ppm (Dose (D) mg/kg)a
Male Female
50 (71) 100 (142) 50 (77) 100 (152)
α-Pineneb
Cmax (ng/g lipid) 663000 1300000 1180000 2530000
Cmax/D (ng/g)/(mg/kg)b 9330 9120 15300 16600
Lambda half-life (h) 8.64 7.58 17.6 24.4
AUC (h*ng/g lipid) 4580000 10600000 28400000 45100000
AUC/D (h*ng/g lipid)/(mg/kg)b 64600 74500 368000 297000
α-Pinene oxidec
Cmax (ng/g lipid) 34800 34800 38300 76600
Lambda half-life (h) 8.10 8.16 8.90 8.28
AUC (h*ng/g lipid) 178000 227000 322000 491000
a

Dose (D) estimated in mg/kg are given in parenthesis.

b

Dose-normalized values were estimated by dividing with the corresponding dose.

c

Based on non-compartmental analysis. Mean values for 3 animals were used in the analysis.

Acronyms used: Cmax, maximum concentration; AUC, area under the plasma concentration versus time curve; CL, clearance; V, volume of distribution.

In male rats, exposure parameters for α-pinene in mammary gland increased proportionally to the dose as evident by Cmax/D (9120–9330 (ng/g)/(mg/kg)) and AUC/D values (64600–74500 (h*ng/g)/(mg/kg)) (Table 3). Systemic exposure in female rats was approximately 2-fold higher than in males based on Cmax and 4- to 6-fold higher based on AUC (Table 3). Elimination half-life of α-pinene in mammary gland was 2- to 3-fold longer in females (17.6–24.4 h) compared to males (7.58–8.64 h).

In male and female rats, α-pinene oxide was detected in the mammary gland. Concentrations were above the LOD of the analytical method at all timepoints. α-Pinene oxide in mammary gland was reported as both ng/g mammary gland and ng/g lipid. The mean mammary gland α-pinene oxide concentration versus time data were evaluated using NCA and the resulting plots are shown in Figure 3B for females and Supplemental Figure 2B for males for both ng/g mammary gland and ng/g lipid. Toxicokinetic parameters are given in Table 3 for lipid normalized values (ng α-pinene/g lipid).

Cmax of α-pinene oxide in mammary gland did not increase with dose of α-pinene in male rats. However, in females, α-pinene oxide Cmax increased 2-fold with the 2-fold increase in dose (Table 3). AUC increased with dose in males and females although the increase was only 1.3- to 1.5-fold with a 2-fold increase in dose. AUC was approximately 2-fold higher in females (322000–491000 h*ng/g) compared to males (178000–227000 h*ng/g). Elimination half-life of α-pinene oxide in mammary gland ranged from 8.10 to 8.90 h with no apparent dose- or sex-related effect (Table 3).

3.5. Blood toxicokinetics of α-pinene and α-pinene oxide in male and female mice

In mice exposed by inhalation to α-pinene at 50 or 100 ppm, α-pinene concentrations in blood were above the LOD at all timepoints. Mean blood concentration versus time data were analyzed using a two-compartment model. The plots showing the data and model fits are shown in Figure 4A and Supplemental Figure 3A for females and males, respectively. TK parameters are presented in Table 4.

Figure 4.

Figure 4.

Blood concentration versus time profiles of A) α-pinene and B) α-pinene oxide in female mice following whole body inhalation exposure to α-pinene for 7 d. Mean data for α-pinene and α-pinene oxide were analyzed using two compartment models and non-compartmental analysis, respectively.

Table 4.

Blood toxicokinetic parameters of α-pinene and α-pinene oxide in male and female mice following whole body inhalation exposure to α-pinene for 7 d.

Exposure concentration, ppm (Dose (D), mg/kg)a
Male Female
50 (117) 100 (233) 50 (116) 100 (231)
α-Pineneb
Cmax (ng/mL) 867 ± 87.2 3310 ± 437 765 ± 3.4 3000 ± 273
Cmax/D (ng/mL)/(mg/kg)d 7.41 14.2 6.59 13.0
Alpha half-life (h) 1.41 ± 0.389 0.647 ± 0.231 1.43 ± 0.386 0.744 ± 0.173
Beta half-life (h) 13.3 ± 32.3 6.18 ± 8.07 19.4 ± 1.6 9.08 ± 8.13
CL1 (mL/h/kg) 55200 ± 13400 51700 ± 12900 51900 ± 18700 44500 ± 9350
CL2 (mL/h/kg) 9840 ± 13000 20100 ± 19100 19100± 18500 23700 ± 12400
V1 (mL/kg) 135000 ± 13600 70400 ± 9310 152000 ± 14600 77000 ± 7020
V2 (mL/kg) 157000± 457000 123000 ± 165000 379000 ± 957000 192000 ± 186000
AUC (h*ng/mL) 2120 ± 516 4510 ± 1120 2230 ± 805 5190 ± 1090
AUC/D (h*ng/mL)/(mg/kg)d 18.1 19.4 19.2 22.5
α-Pinene oxided
Cmax (ng/mL) 52.4 97.7 65.8 102
Lambda half-life (h) 7.70 7.91 1.31 2.37
AUC (h*ng/mL) 222 207 79.8 170
a

Dose (D) estimated in mg/kg are given in parenthesis.

b

Based on two compartment model with bolus input, first-order output and 1/y weighting. Values given are mean ± standard error for 3 animals.

c

Dose-normalized values were estimated by dividing with the corresponding dose.

d

Based on non-compartmental analysis. Mean values for 3 animals were used in the analysis.

Acronyms used: Cmax, maximum concentration; AUC, area under the plasma concentration versus time curve; CL, clearance; V, volume of distribution.

In both male and female mice, blood α-pinene Cmax increased with the dose. The increase was more than proportional to the dose and was similar between the sexes; Cmax /D was 7.41 and 14.2 (ng/mL)/(mg/kg) for males and 6.59 and 13.0 (ng/mL)/(mg/kg) for females (Table 4). Unlike Cmax, AUC increased proportionally to the dose (AUC/D 18.1–22.5 ((h*ng/mL)/(mg/kg)) and was similar between sexes (Table 4). The elimination half-life (beta half-life) of α-pinene decreased with increasing dose in both sexes; values for males were 13.3 and 6.18 h and for females were 19.4 and 9.08 h for the low and high dose, respectively, and was slightly longer in females compared to males (Table 4).

Following exposure of male and female mice to α-pinene, α-pinene oxide was measured in blood. α-Pinene oxide concentrations in blood were above the LOD at all timepoints except the following timepoints where values were below the LOD: male mice 50 ppm 48 h and 100 ppm 24–48 h; female mice 50 ppm 12–48 h and 100 ppm 24–48 h. Mean blood concentration versus time data were evaluated using NCA. The plots showing the data and model fits are shown in Figure 4B and Supplemental Figure 3B. TK data are given in Table 4. In male and female mice, α-pinene oxide Cmax increased linearly with the dose with no apparent sex difference. AUC increased proportionally to the dose in females although in males AUC didn’t increase with the dose. Elimination half-life of α-pinene oxide in male mouse blood (7.70–7.91 h) was longer than in female blood (1.31–2.37 h) with no apparent dose-related difference (Table 4).

3.6. Mammary gland toxicokinetics of α-pinene and α-pinene oxide in male and female mice

In male and female mice, α-pinene concentrations in mammary glands were above the LOD of the analytical method at all timepoints. α-Pinene in mammary glands was reported as both ng/g mammary gland and ng/g lipid. For TK analysis, mean concentration versus time data were evaluated using NCA. The plots showing the data and model fits are shown in Figure 5A for female mice and Supplemental Figure 4A for males. Toxicokinetic parameters are given in Table 5 for lipid normalized values (ng α-pinene/g lipid).

Figure 5.

Figure 5.

Mammary gland concentration versus time profiles of A) α-pinene and B) α-pinene oxide in female mice following whole body inhalation exposure to α-pinene for 7 days. Mean data were analyzed using non-compartmental analysis. Open and closed symbols represent ng/g mammary and ng/g lipid, respectively.

Table 5.

Mammary gland toxicokinetic parameters of α-pinene and α-pinene oxide in male and female mice following inhalation exposure to alpha pinene for 7 d.

Exposure concentration, ppm (Dose (D), mg/kg)a
Male Female
50 (117) 100 (233) 50 (116) 100 (231)
α-Pineneb
Cmax (ng/g lipid) 665000 2850000 643000 1500000
Cmax/D (ng/g lipid)/(mg/kg)c 5680 12200 5550 6510
Half-life (h) 7.65 5.01 8.90 5.77
AUC (h*ng lipid/g) 1900000 6740000 3340000 9050000
AUC/D (h*ng/g lipid)/(mg/kg)c 16200 28900 28800 39200
α-Pinene oxideb
Cmax (ng lipid/g) 8130 9130 5000 6290
Half-life (h) 2.89 3.28 2.36 3.03
AUC (h*ng/g lipid) 15500 36200 12900 19300
a

Dose (D) estimated in mg/kg are given in parenthesis.

b

Based on non-compartmental analysis. Mean values for 3 animals were used in the analysis.

c

Dose-normalized values were estimated by dividing with the corresponding dose.

Acronyms used: Cmax, maximum concentration; AUC, area under the plasma concentration versus time curve.

In mammary glands of male mice, α-pinene Cmax/D (5680–12200 (ng/g)/(mg/kg)) and AUC/D (16200–28200 (h*ng/g)/(mg/kg)) increased with the dose demonstrating a more than dose-proportional increase. Although a similar pattern was observed in females, the increase was marginal (Table 5). At the low dose, Cmax values of males and females were similar although at the high dose, males had approximately 2-fold higher levels than females. In contrast, AUC values were slightly higher in females compared to males (Table 5). Although the elimination half-lives of α-pinene in mammary glands were approximately similar between sexes, an apparent decrease in half-life with the increase in dose was observed with 7.65 and 5.01 h for males and 8.90 and 5.77 h for females, for low and high dose, respectively (Table 5).

α-Pinene oxide was measured in mammary glands of male and female mice. Concentrations were above the LOD except the following; male 50 ppm 48 h, male 100 ppm 24–48 h, female 50 ppm 24–48 h, female 100 ppm 48h. α-Pinene oxide in mammary glands was reported as both ng/g mammary and ng/g lipid. Mean mammary gland concentration versus time data were evaluated using NCA. The plots showing the data and model fits are shown in Figure 5B and Supplemental Figure 4B for females and males, respectively. Toxicokinetic parameters are given in Table 5 for lipid normalized values.

Cmax of α-pinene oxide increased only marginally with dose in male mice with 8130 and 9130 ng/g for low and high dose, respectively. In females, a similar behavior was observed but the concentrations were lower than males (Table 5). AUC increased proportionally to the dose in male mice (15500–36200 (h*ng/g)), but in females (12900–19300 (h*ng/g)), the increase was less-than proportional to the α-pinene dose. Elimination half-life of α-pinene oxide in mouse mammary glands ranged from 2.36 to 3.28 h with no apparent dose- or sex-related difference (Table 5).

4. Discussion

Due to widespread exposure and limited data available to characterize the potential hazard from exposure to α-pinene, the NTP is investigating the chronic toxicity and carcinogenicity of α-pinene following whole body inhalation exposure of rats (0, 50, 100, and 200 ppm) and mice (0, 100, 200, and 400 ppm) to α-pinene (NTP, 2020). The current investigation was aimed at generating TK data for α-pinene in blood and mammary glands to put toxicological findings into greater context. We also investigated the formation of α-pinene oxide, a potential reactive metabolite of α-pinene. The whole body inhalation exposure was selected to mimic human exposure scenario, to ensure minimal stress, and free movement of animals. There is a potential for oral exposure via grooming of the test material that may have been collected on animal fur although it is expected to be minimal. To the best of our knowledge, this is the first study investigating the TK behavior of α-pinene and α-pinene oxide following inhalation exposure to α-pinene in rodents.

In rats of both sexes, the systemic exposure to α-pinene increased with the dose (or exposure concentration). The increase in blood Cmax was more-than dose proportional in both sexes with an 8- to 9-fold increase with a 2-fold increase in the dose whereas the increase in AUC was dose-proportional. Females had a higher systemic exposure than males. Based on blood Cmax and AUC, respectively, the exposure in females was ~ 1.5-fold and ~ 2-fold higher than in males, respectively. Although the reasons for the sex difference is not clear, this finding is consistent with the higher sensitivity observed in female rats compared to male rats in NTP subchronic studies following inhalation exposure to α-pinene (NTP, 2016). Similar to rats, in mice, Cmax of α-pinene increased more-than proportionally to the dose and the increase was approximately 4-fold with a 2-fold increase in the dose while the increase in AUC was dose proportional. However, unlike in rats, there was no sex difference in systemic exposure to α-pinene in mice. When the magnitude of systemic exposure to α-pinene is compared between rats and mice, male and female rats had higher exposure than male and female mice. Based on both dose-normalized Cmax and AUC male rats had 2–4-fold higher exposure than male mice. A similar comparison in females showed that female rats had 3–5-fold higher exposure than female mice. However, at the present time, the reasons for the observed species difference is unclear.

Falk et al. reported blood TK data in humans following a 2-h inhalation exposure for up to 450 mg/m3 α-pinene (N=8, average body weight 80 kg) (Falk et al., 1990). At 450 mg/m3, authors reported a total given amount of 9.3 mmol (~1265 mg) α-pinene which translates to a dose of 15.8 mg/kg α-pinene using an average body weight of 80 kg. α-Pinene concentration in blood increased with the exposure duration and declined after cessation of exposure. According to Figure 2 of Falk et al, Cmax was approximately ~19 mmol/L (2589 ng/mL) for 450 mg/m3 exposure group giving a dose-normalized Cmax (Cmax /D) value of 164 (ng/mL)/(mg/kg) (Table 6). Cmax/D values for rats and mice from the current study following inhalation exposure to α-pinene for 7 d are also given in Table 6 to allow for direct species comparison. Based on these data, human systemic exposure to a unit dose of α-pinene exposure was 2- to 13-fold higher than rats and 12- to 25-fold higher than mice (Table 6). Although authors didn’t report the AUC value for humans following exposure to α-pinene, a clearance of 1.09 L/h/kg was reported after cessation of exposure to 450 mg/m3 (estimated dose 15.8 mg/kg) (Falk et al., 1990). Using the clearance value and the dose of α-pinene, we estimated an AUC value of 14,505 h*ng/mL (AUC = dose/clearance) and subsequently a dose-normalized AUC value of 917 (ng*h/mL)/(mg/kg) in humans following a single 2 h exposure (Table 6). A comparison of the dose-normalized AUC between humans and rodents demonstrated that for a unit exposure to α-pinene, human systemic exposures are 16- to 32-fold and 41- to 51-fold higher than that in rats and mice, respectively. Collectively, these comparisons using Cmax and AUC values demonstrate that for a unit dose of α-pinene exposure, humans have higher systemic exposure to α-pinene than rodents. However, we would like to reiterate that the experimental designs differed between humans and rodents and should be carefully considered prior to making definitive conclusions between human and rodent data. Terminal elimination half-life reported in Falk et al was 695 min (~ 11.6 h) (Falk et al., 1990) and was similar to beta half-lives estimated in our investigation for rats (12.2–17.4 h) and mice (6.16–19.4 h) indicating some similarities in excretion kinetics between rodents and humans.

Table 6.

Comparison of systemic exposure to α-pinene in rodents and humans following inhalation exposure to α-pinene

Species (sex) Exposure Concentration (ppm) Dose (mg/kg) Dose-normalized Cmax (Cmax/D) (ng/mL)/(mg/kg)a Dose-normalized AUC (AUC/D) (ng*h/mL)/(mg/kg)b Cmax/D Ratio Human/rodentc AUC/D Ratio Human/rodentd
Rat (male) 50 71 12.2 28.9 13 32
Rat (male) 100 142 54.5 31.1 3 30
Rat (female) 50 77 17.4 55.8 9 16
Rat (female) 100 152 71.1 56.8 2 16
Mouse (male) 50 117 7.41 18.1 22 51
Mouse (male) 100 233 14.2 19.4 12 47
Mouse (female) 50 116 6.59 19.2 25 48
Mouse (female) 100 231 13.0 22.5 13 41
Human (male)e 81 15.8 164 917 - -
a

Cmax per unit dose.

b

AUC per unit dose.

c

Ratio of human to rodent based on Cmax per unit dose.

d

Ratio of human to rodent based on AUC per unit dose.

e

Data are from Falk et al., 1994. Total given amount was 9.3 mmol (=1265 mg AP) for 450 mg/m3 (81 ppm) group. Using an average body weight of 80 kg, dose (mg/kg) was estimated as 15.8 mg/kg (1265 mg/80 kg). Cmax of 2589 ng/mL was estimated from Figure 2 and a dose-normalized Cmax of 164 (ng/mL)/(mg/kg). AUC of 14505 h*ng/mL was estimated from clearance reported (1.09 L/h.kg) and dose (15.8 mg/kg) (AUC= dose/clearance) and subsequently the dose-normalized AUC of 917 (ng*h/mL)/(mg/kg).

The α-pinene exposure in mammary glands increased proportionally to the dose based on both Cmax and AUC values. The exposure in female rat was ~2-fold and 4- to 5-fold higher based on Cmax and AUC, respectively, than in males. Unlike in rats, in mice, the increase in Cmax and AUC of α-pinene was more than dose proportional although the pattern was less evident in females. With a 2-fold increase in dose, Cmax and AUC, respectively, increased 4- and 3.5-fold in male mice, 2.3- and 2.7-fold in female mice demonstrating that the exposures between the sexes in mice were within 2-fold. When α-pinene in rat and mice mammary gland were compared using dose-normalized Cmax and AUC, respectively, male rats had ~ 0.75- to 1.6-fold and ~ 2.6- to 4-fold higher exposure than male mice. A similar comparison in females showed that female rats had ~ 3-fold and ~ 8- to 13-fold higher exposure, based on Cmax and AUC, respectively, than female mice. Collectively, these data demonstrate that rats had higher internal exposure to α-pinene in mammary glands than mice to a unit dose of exposure and the difference was higher in females than in males.

A potential reactive metabolite, α-pinene oxide, was present in rats and mice and was quantifiable in both blood and mammary glands. Although the formation of α-pinene oxide has been previously reported in rat liver microsomes in limited studies (White et al., 1979; White et al., 1980), to the best of our knowledge, this is the first investigation reporting the formation of α-pinene oxide from metabolism of α-pinene, in vivo. In male and female rat and mouse blood, the increase in α-pinene oxide was less than dose-proportional for both Cmax and AUC and the values in males and females were within 2-fold. In rat and mouse mammary glands, exposure to α-pinene oxide increased with the dose but the increase was less than dose-proportional except for male mouse AUC, where the increase was dose-proportional.

The extent of α-pinene oxide formation following metabolism of α-pinene was determined by computing the ratio of α-pinene oxide to α-pinene using Cmax values (Figure 6A and Supplemental Table 2). Based on blood Cmax values for the low dose, rats had higher α-pinene oxide formed (ratio 0.200–0.237) than mice (ratio 0.060.−0.086); females had higher values than males in both species (Figure 6A). The α-pinene oxide formed was lower at the high dose (ratio rats, 0.028–0.046; ratio mice, 0.030–0.034) compared to the low dose and the decrease was more evident in rats than in mice; there was no distinct species and sex difference in the ratio of α-pinene oxide to α-pinene at the high dose. These data point to either the saturation of metabolic pathways leading to the formation of α-pinene oxide and/or induction of subsequent metabolic pathways (e.g., epoxide hydrolases) in both species and sexes with the increase in dose. The ratio of α-pinene oxide to α-pinene in mammary glands was lower than in blood; however, similar to blood, rats (ratio 0.027–0.052) had higher conversion of α-pinene to α-pinene oxide than mice (ratio 0.003–0.012) for both doses. As with blood, a lower ratio of α-pinene oxide to α-pinene was formed at the higher dose in both species and sexes (Figure 6A, Supplemental Table 2).

Figure 6.

Figure 6.

Ratio of α-pinene oxide formed from α-pinene estimated based on A) maximum concentration (Cmax) and B) area under the concentration time curve (AUC)

A similar comparison using AUC values is given in Figure 6B and Supplemental Table 2. In general, the pattern was similar to that seen with Cmax: 1) blood and mammary glands of rats had higher α-pinene oxide formation than mice, in both sexes, 2) mammary glands had lower α-pinene oxide formation than blood in both species and sexes, and 3) the ratio of α-pinene oxide to α-pinene formed decreased with the dose. However, unlike observations with blood Cmax revealing female rats and mice had higher α-pinene oxide formed compared to corresponding males at the low dose, for AUC, the opposite was seen where male rats and mice consistently showed higher α-pinene oxide formed in both blood and mammary glands than corresponding females. Taken collectively, the data showed that the amount of α-pinene oxide formed was dose-, species-, sex- and tissue-dependent

Based on lipid-unadjusted Cmax and AUC values of mammary glands (ng α-pinene or α-pinene oxide/g mammary gland and assuming a density of 1 g/mL for mammary for direct comparison with blood), concentrations of both α-pinene and α-pinene oxide in mammary gland was higher than in blood. For α-pinene, tissue to blood ratios based on Cmax and AUC, respectively, were ≥ 23 and ≥ 253 in rats and ≥ 97 and ≥ 271 in mice demonstrating accumulation of α-pinene in mammary glands in rats and mice (Supplemental Table 3). Similar observations were noted for α-pinene oxide, with tissue to blood ratios ranging from 29 to 74 with no apparent species or sex difference (Supplemental Table 3).

Comparison of human and rodent TK data for α-pinene showed that humans have higher systemic exposure per unit exposure than rodents albeit with some differences between the exposure paradigms. In addition, the data from the current investigation demonstrated the formation of a potential reactive metabolite, α-pinene oxide, from the metabolism of α-pinene following inhalation exposure in male and female rats and mice which may have implications for the potential toxicity of α-pinene in rodents. Further investigation into metabolism of α-pinene to α-pinene oxide in human in vitro and in vivo models is important to evaluate the relevance of rodent toxicology study findings to human exposures.

5. Conclusion

Our data demonstrated that inhaled α-pinene was systemically absorbed in male and female rats and mice and distributed to mammary glands. In general, α-pinene concentration in blood and mammary glands in rats was higher than in mice, and female rats had higher exposure than male rats, although in mice, no distinct sex difference was observed. α-Pinene concentration in mammary glands was higher than in blood demonstrating retention there, likely due to high lipophilicity of α-pinene. α-Pinene oxide, a potential reactive metabolite was quantified in blood and mammary glands. The ratio of α-pinene oxide to α-pinene, in general, was higher in rats than in mice and was higher in blood than in mammary gland. The formation of α-pinene oxide was dose-dependent with higher ratio observed at the low dose than the high dose suggesting potential saturation of metabolism with the increasing dose. Because α-pinene is a common indoor air pollutant, the observed species- and sex-dependent TK behavior of α-pinene, along with high tissue retention and formation of α-pinene oxide may be of relevance to human health following exposure to this compound.

Supplementary Material

72265ACA109D7FCE22DB23D0B43DA75F

6. Acknowledgements

The authors are grateful to Mr. Bradley Collins and Dr. Stephen Ferguson for their review of this manuscript. This work was supported by the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences, Intramural Research project ZIA ES103316–04, and performed for the National Toxicology Program, National Institute of Environmental Health Sciences, National Institutes of Health, U.S. Department of Health and Human Services, under contracts HHSN273201400015C (Battelle, Columbus, OH) and HHSN273201400022C (TK data analysis; RTI International, RTP, NC).

Footnotes

Declaration of Interest

The authors report no declarations of interest.

7. References

  1. Burdock GA, 2010. Fenaroli’s handbook of flavor ingredients. 6th ed. Boca Raton (FL): CRC Press. [Google Scholar]
  2. Catanzaro I, Caradonna F, Barbata G, Saverini M, Mauro M, Sciandrello G, 2012. Genomic instability induced by alpha-pinene in Chinese hamster cell line. Mutagenesis 27, 463–469. [DOI] [PubMed] [Google Scholar]
  3. de Carvalho CC, da Fonseca MM, 2006. Biotransformation of terpenes. Biotechnol Adv 24, 134–142. [DOI] [PubMed] [Google Scholar]
  4. De Roos AJ, Olshan AF, Teschke K, Poole C, Savitz DA, Blatt J, Bondy ML, Pollock BH, 2001. Parental occupational exposures to chemicals and incidence of neuroblastoma in offspring. Am J Epidemiol 154, 106–114. [DOI] [PubMed] [Google Scholar]
  5. Demers PA, Teschke K, Davies HW, Kennedy SM, Leung V, 2000. Exposure to dust, resin acids, and monoterpenes in softwood lumber mills. AIHAJ 61, 521–528. [DOI] [PubMed] [Google Scholar]
  6. EPA, 1988. Recommendations for and documentation of biological values for use in risk assessment. United States Environmental Protection Agency, Washington, DC, EPA/600/6–87/008 (NTIS PB88179874). [Google Scholar]
  7. EPA, 1994. Methods for derivation of inhalation reference concentrations and application of inhalation dosimetry. United States Environmental Protection Agency, Office of Research and Development, Office of Health and Environmental Assessment, Washington, DC, EPA/600/8–90/066F. [Google Scholar]
  8. EPA, 2020. Alpha Pinene (https://comptox.epa.gov/dashboard/dsstoxdb/results?search=7785-70-8#production-volume) (Last accessed July 2020).
  9. Eriksson K, Levin JO, 1996. Gas chromatographic-mass spectrometric identification of metabolites from alpha-pinene in human urine after occupational exposure to sawing fumes. J Chromatogr B Biomed Appl 677, 85–98. [DOI] [PubMed] [Google Scholar]
  10. EU, 2020. European Union. 2016 Food Flavourings Database [database]. Brussels (BE): European Commission Directorate-General for Health and Consumers. [accessed 2018]. https://ec.europa.eu/food/safety/food_improvement_agents/flavourings/eu_lists_flavourings_en (Lact accessed July 2020). [Google Scholar]
  11. Falk AA, Hagberg MT, Lof AE, Wigaeus-Hjelm EM, Wang ZP, 1990. Uptake, distribution and elimination of alpha-pinene in man after exposure by inhalation. Scand J Work Environ Health 16, 372–378. [DOI] [PubMed] [Google Scholar]
  12. FCC, 2018. Food Chemicals Codex. 1th Edition. Washington, D.C.National Academy Press. . [Google Scholar]
  13. FDA, U.S., 2018. Substances Added to Food. https://www.fda.gov/food/food-additives-petitions/substances-added-food-formerly-eafus (Lasr Accessed July 26, 2020).
  14. FEMA, 2020. Flavor and Extract Manufacturers Association. https://www.femaflavor.org/flavor-library (Last accessed July 2020).
  15. Fenton SE, 2009. The mammary gland: a tissue sensitive to environmental exposures. Rev Environ Health 24, 319–325. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Fernando R, Fennell TR, Watson SL, Silinski MAR, Blake JC, Robinson VG, Waidyanatha S, 2020. Development and Validation of an Analytical Method for Quantitation of Alpha-pinene oxide in Rodent Blood and Mammary Tissue by GC-MS. J Anal Toxicol Accepted. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Filipsson AF, 1996. Short term inhalation exposure to turpentine: toxicokinetics and acute effects in men. Occup Environ Med 53, 100–105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Fransman W, McLean D, Douwes J, Demers PA, Leung V, Pearce N, 2003. Respiratory symptoms and occupational exposures in New Zealand plywood mill workers. Ann Occup Hyg 47, 287–295. [DOI] [PubMed] [Google Scholar]
  19. HC, 2020. Health Canada. Draft screening assessment - Terpenes and Terpenoids - Acyclic, Monocyclic, and Bicyclic Monoterpenes Group. https://www.canada.ca/en/environment-climate-change/services/evaluating-existing-substances/draft-screening-assessment-terpene-terpenoids-acyclic-monocyclic-bicyclic-monoterpenes-group.html. Last accessed August 22, 2020.
  20. Hedenstierna G, Alexandersson R, Wimander K, Rosen G, 1983. Exposure to terpenes: effects on pulmonary function. Int Arch Occup Environ Health 51, 191–198. [DOI] [PubMed] [Google Scholar]
  21. Johnson KR, Ellis G, Toothill C, 1977. The sulfophosphovanillin reaction for serum lipids: a reappraisal. Clin Chem 23, 1669–1678. [PubMed] [Google Scholar]
  22. Kauppinen TP, Partanen TJ, Hernberg SG, Nickels JI, Luukkonen RA, Hakulinen TR, Pukkala EI, 1993. Chemical exposures and respiratory cancer among Finnish woodworkers. Br J Ind Med 50, 143–148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Kim S, Thiessen PA, Bolton EE, Chen J, Fu G, Gindulyte A, Han L, He J, He S, Shoemaker BA, Wang J, Yu B, Zhang J, Bryant SH, 2016. PubChem Substance and Compound databases. Nucleic Acids Res 44, D1202–1213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Koppel C, Tenczer J, Tonnesmann U, Schirop T, Ibe K, 1981. Acute poisoning with pine oil - metabolism of monoterpenes. Arch Toxicol 49, 73–78. [DOI] [PubMed] [Google Scholar]
  25. Mercier B, Prost J, Prost M, 2009. The essential oil of turpentine and its major volatile fraction (alpha- and beta-pinenes): a review. Int J Occup Med Environ Health 22, 331–342. [DOI] [PubMed] [Google Scholar]
  26. Nazaroff WW, Singer BC, 2004. Inhalation of hazardous air pollutants from environmental tobacco smoke in US residences. J Expo Anal Environ Epidemiol 14 Suppl 1, S71–77. [DOI] [PubMed] [Google Scholar]
  27. NIOSH, 2020. NIOSH pocket guide to chemical hazards. Atlanta, GA: Department of Health and Human Services, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health. https://www.cdc.gov/niosh/docs/2010-168c/. Last accessed July 2020. [Google Scholar]
  28. NRC, 2011. Guide for the Care and Use of Laboratory Animals: Eighth Edition. Washington, DC: The National Academies Press. [Google Scholar]
  29. NTP, 2016. NTP Technical Report on the Toxicology Studies of alpha pinene (CASRN 80–56-8) administered by inhalation to F344/N Rats and B6C3F1/N Mice. https://ntp.niehs.nih.gov/publications/reports/tox/000s/tox081/index.html?utm_source=direct&utm_medium=prod&utm_campaign=ntpgolinks&utm_term=tox081abs Last accessed July 2020.
  30. NTP, 2020. Testing status of alpha pinene. https://ntp.niehs.nih.gov/whatwestudy/testpgm/status/ts-m030014.html?utm_source=direct&utm_medium=prod&utm_campaign=ntpgolinks&utm_term=ts-m030014 Last accessed July 2020.
  31. Phillips MA, Savage TJ, Croteau R, 1999. Monoterpene synthases of loblolly pine (Pinus taeda) produce pinene isomers and enantiomers. Arch Biochem Biophys 372, 197–204. [DOI] [PubMed] [Google Scholar]
  32. PubChem, 2020. Alpha pinene-Use and Manufacturing https://pubchem.ncbi.nlm.nih.gov/compound/6654 Last accessed July 2020.
  33. Rastogi SC, Heydorn S, Johansen JD, Basketter DA, 2001. Fragrance chemicals in domestic and occupational products. Contact Dermatitis 45, 221–225. [DOI] [PubMed] [Google Scholar]
  34. Rosenberg C, Liukkonen T, Kallas-Tarpila T, Ruonakangas A, Ranta R, Nurminen M, Welling I, Jappinen P, 2002. Monoterpene and wood dust exposures: work-related symptoms among Finnish sawmill workers. Am J Ind Med 41, 38–53. [DOI] [PubMed] [Google Scholar]
  35. Silinski MAR, Licause J, Uenoyama T, Blake JC, Fernando RA, Robinson VG, Waidyanatha S, 2020. Development and Validation of an Analytical Method for Quantitation of Alpha-pinene in Rodent Blood and Mammary Tissue by Headspace GC-MS. J Anal Toxicol accepted. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. White RA, Agosin M, Franklin RT, Webb JW, 1980. Bark Beetle Pheromones - Evidence for Physiological Synthesis Mechanisms and Their Ecological Implications. Z Angew Entomol 90, 255–274. [Google Scholar]
  37. White RA, Franklin RT, Agosin M, 1979. Conversion of Alpha-Pinene to Alpha-Pinene Oxide by Rat-Liver and the Bark Beetle Dendroctonus-Terebrans Microsomal Fractions. Pestic Biochem Phys 10, 233–242. [Google Scholar]
  38. WHO, 2006. Safety evaluation of certain food additives. Sixty-third meeting of the Joint FAO/WHO Expert Committee on Food additives (JECFA). Who Food Additives Series: 54. Geneva: World Health Organization. [Google Scholar]
  39. Zhu J, Wong SL, Cakmak S, 2013. Nationally representative levels of selected volatile organic compounds in Canadian residential indoor air: population-based survey. Environ Sci Technol 47, 13276–13283. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

72265ACA109D7FCE22DB23D0B43DA75F

RESOURCES